Parkside Financial Bank & Trust’s Genmab GMAB Stock Holding History

Parkside Financial Bank & Trust’s Portfolio GMAB Stock Details GMAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$8.96K	Hold	334	–	–	﹤0.01%	1625
2025 Q4	$10.3K	Hold	334	–	–	﹤0.01%	1566
2025 Q3	$10.2K	Hold	334	–	–	﹤0.01%	1510
2025 Q2	$6.9K	Buy	334 +142	+74%	+$2.92K	﹤0.01%	1607
2025 Q1	$3.76K	Buy	192 +90	+88%	+$1.89K	﹤0.01%	1719
2024 Q4	$2.13K	Sell	102 -30	-23%	-$659	﹤0.01%	1616
2024 Q3	$3.22K	Hold	132	–	–	﹤0.01%	1517
2024 Q2	$3.32K	Hold	132	–	–	﹤0.01%	1452
2024 Q1	$3.95K	Hold	132	–	–	﹤0.01%	1391
2023 Q4	$4.2K	Buy	+132	New	+$4.14K	﹤0.01%	1347

Other funds holding GMAB

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Parkside Financial Bank & Trust's GMAB Position: Q1 2026 in Review

Parkside Financial Bank & Trust held its Genmab (GMAB) position steady in Q1 2026 at 334 shares worth $8.96K. The position accounts for ﹤0.01% of the portfolio, ranked #1625.

Parkside Financial Bank & Trust first reported a position in GMAB in Q4 2023 and has held it in 10 quarters since. The position peaked at $10.3K in Q4 2025. 274 funds tracked by Wall St. Rank hold GMAB as of Q1 2026.

Parkside Financial Bank & Trust held 334 shares of Genmab worth $8.96K as of Q1 2026.
Parkside Financial Bank & Trust left its Genmab share count unchanged in Q1 2026.
Genmab made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q1 2026, its #1625 holding.
Parkside Financial Bank & Trust first reported a position in Genmab in Q4 2023 and has held it in 10 quarters since.
Parkside Financial Bank & Trust's Genmab position peaked at $10.3K in Q4 2025.
274 funds tracked by Wall St. Rank held Genmab as of Q1 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q1 2026, filed 13 May 2026.